Table 2.
Anti-neoplastic effects of NDV in non-permissive hosts.
| Targeting the oncogenic protein Rac1 |
| Tumor-selective virus replication |
| Tumor-selective oncolysis |
| Tumor-selective induction of immunogenic cell death |
| Potential to break T cell tolerance towards tumor-associated antigen (TA) expressing tumor cells |
| Potential to break resistance to chemotherapy or radiotherapy |
| Potential to break resistance to apoptosis |
| Potential to break resistance to hypoxia |
| Potential to break resistance to TNF-related apoptosis-inducing ligand (TRAIL) |
| Potential to break resistance to immune checkpoint blockade |
| Potential to break resistance to anti-viral immunity |
| Promotion of virus propagation via syncytia, autophagy, and exosomes |